Roche Collaborates with Aileron to Develop Stapled Peptide Therapeutics
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 8 (Table of Contents)
Published: 13 Oct-2010
DOI: 10.3833/pdr.v2010.i8.1384 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Recognising the potential of Aileron Therapeutics’ peptide stabilisation technology, Roche has entered into a collaborative agreement with the company to develop drug candidates against five disease targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018